Laura A. Murray-Nerger, Benjamin E. Gewurz
{"title":"Efficient CRISPR/Cas9 Knock-in Approaches for Manipulation of Endogenous Genes in Human B Lymphoma Cells","authors":"Laura A. Murray-Nerger, Benjamin E. Gewurz","doi":"10.1002/cpz1.70041","DOIUrl":null,"url":null,"abstract":"<p>Precise understanding of temporally controlled protein-protein interactions, localization, and expression is often difficult to achieve using traditional overexpression techniques. Recent advances have made CRISPR-based knock-in approaches efficient, which enables rapid derivation of cells with tagged endogenous proteins. However, the high degree of variability in knock-in efficiency across cell types and gene loci poses challenges, in particular with B lymphocytes, which are refractory to lipid transfection. Here, we present detailed protocols for efficient B lymphoma cell CRISPR/Cas9-mediated knock-in. We address knock-in efficiency in two ways. First, we provide a detailed approach for assessing cutting efficiency to select the most efficient single guide RNA for the gene region of interest. Second, we provide detailed approaches for tagging endogenous proteins with a fluorescent marker or instead for co-expressing them with an unlinked fluorescent marker. Either approach facilitates downstream selection of single-cell or bulk populations with the desired knock-in, particularly when knock-in efficiency is low. The utility of this approach is demonstrated via examples of engineering tags onto endogenous protein N- or C-termini, together with downstream analyses. We anticipate that this workflow can be applied more broadly to other cell types for efficient knock-in into endogenous loci. © 2024 Wiley Periodicals LLC.</p><p><b>Basic Protocol 1</b>: Choosing an optimal knock-in target site and single guide RNA (sgRNA) design</p><p><b>Basic Protocol 2</b>: Assessment of Cas9 editing efficiency at the desired B cell genomic knock-in site</p><p><b>Basic Protocol 3</b>: Cloning the sgRNA dual guide construct</p><p><b>Basic Protocol 4</b>: Repair template design and cloning</p><p><b>Basic Protocol 5</b>: Electroporation and selection of engineered B cells</p><p><b>Basic Protocol 6</b>: Single-cell cloning of engineered B cells</p>","PeriodicalId":93970,"journal":{"name":"Current protocols","volume":"4 11","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current protocols","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cpz1.70041","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Precise understanding of temporally controlled protein-protein interactions, localization, and expression is often difficult to achieve using traditional overexpression techniques. Recent advances have made CRISPR-based knock-in approaches efficient, which enables rapid derivation of cells with tagged endogenous proteins. However, the high degree of variability in knock-in efficiency across cell types and gene loci poses challenges, in particular with B lymphocytes, which are refractory to lipid transfection. Here, we present detailed protocols for efficient B lymphoma cell CRISPR/Cas9-mediated knock-in. We address knock-in efficiency in two ways. First, we provide a detailed approach for assessing cutting efficiency to select the most efficient single guide RNA for the gene region of interest. Second, we provide detailed approaches for tagging endogenous proteins with a fluorescent marker or instead for co-expressing them with an unlinked fluorescent marker. Either approach facilitates downstream selection of single-cell or bulk populations with the desired knock-in, particularly when knock-in efficiency is low. The utility of this approach is demonstrated via examples of engineering tags onto endogenous protein N- or C-termini, together with downstream analyses. We anticipate that this workflow can be applied more broadly to other cell types for efficient knock-in into endogenous loci. © 2024 Wiley Periodicals LLC.
Basic Protocol 1: Choosing an optimal knock-in target site and single guide RNA (sgRNA) design
Basic Protocol 2: Assessment of Cas9 editing efficiency at the desired B cell genomic knock-in site
Basic Protocol 3: Cloning the sgRNA dual guide construct
Basic Protocol 4: Repair template design and cloning
Basic Protocol 5: Electroporation and selection of engineered B cells
Basic Protocol 6: Single-cell cloning of engineered B cells
操纵人类 B 淋巴瘤细胞内源基因的高效 CRISPR/Cas9 基因敲入方法。
使用传统的过表达技术往往难以精确了解时间控制的蛋白质-蛋白质相互作用、定位和表达。最近的进步使得基于 CRISPR 的基因敲入方法变得高效,从而可以快速衍生出带有标记内源蛋白的细胞。然而,不同细胞类型和基因位点的基因敲入效率差异很大,这给研究带来了挑战,尤其是对脂质转染有耐受性的 B 淋巴细胞。在这里,我们介绍了 B 淋巴瘤细胞 CRISPR/Cas9 介导的高效基因敲入的详细方案。我们通过两种方法提高基因敲入的效率。首先,我们提供了评估切割效率的详细方法,以便为感兴趣的基因区域选择最有效的单一引导 RNA。其次,我们提供了用荧光标记物标记内源蛋白或用非连接荧光标记物共同表达内源蛋白的详细方法。无论哪种方法,都有利于下游选择具有所需基因敲入的单细胞或群体,尤其是在基因敲入效率较低的情况下。通过在内源性蛋白质 N 端或 C 端工程标记的实例以及下游分析,证明了这种方法的实用性。我们预计这种工作流程可以更广泛地应用于其他细胞类型,以高效地敲入内源基因座。© 2024 Wiley Periodicals LLC.基本程序 1:选择最佳基因敲入靶位点和单导 RNA (sgRNA) 设计 基本程序 2:评估在所需 B 细胞基因组基因敲入位点的 Cas9 编辑效率 基本程序 3:克隆 sgRNA 双导构建体 基本程序 4:修复模板设计和克隆 基本程序 5:电穿孔和筛选工程 B 细胞 基本程序 6:工程 B 细胞的单细胞克隆。
本文章由计算机程序翻译,如有差异,请以英文原文为准。